# Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial

> **NCT02223520** · NA · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 307 (actual)

## Conditions studied

- Staph Aureus Colonization
- Staph Aureus Infection

## Interventions

- **DRUG:** Mupirocin and Chlorhexidine
- **DRUG:** Placebo ointment and placebo cloths

## Key facts

- **NCT ID:** NCT02223520
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2022-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02223520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02223520, "Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02223520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*